ESSA Pharma Inc.
CIK 0001633932
Revenue (TTM)
—
Q3 Aug 2025
Net Income (TTM)
−$26.14M
−7.4% YoY
Q3 Aug 2025
EPS Diluted (TTM)
−$0.59
−6.7% YoY
Q3 Aug 2025
Gross Margin
—
Q3 Aug 2025
Operating Margin
—
Q3 Aug 2025
Net Margin
—
Q3 Aug 2025
Free Cash Flow (TTM)
—
Q3 Aug 2025
Cash
$85.95M
Q3 Aug 2025
Total Debt
$0
Q3 Aug 2025
Shares Outstanding
47.31M sh
Q3 Aug 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.